Ophthalmology · Jackson Heights, NY
NPI
1043206469
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8201 37th Ave, 4th Floor
Jackson Heights, NY, 11372
Phone (718) 424-0303
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
922 services
Medicare patients, 2024
196
Average age 77
Drug cost, 2024
$5.1M
15,459 prescriptions
Company payments, 2025
$2,988
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jacqueline Dauhajre was code 92012 (ophthalmological e&m), 141 times for 94 patients. In total Jacqueline Dauhajre billed 922 services in 22 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 141 | 94 | $64.33 | $9,070 |
| 68761 Eye | Office | 94 | 39 | $75.42 | $7,089 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Office | 92 | 38 | $208.52 | $19K |
| 92020 Ophthalmological E&M | Office | 86 | 76 | $21.66 | $1,863 |
| 92083 Vision, Hearing, and Speech Services | Office | 69 | 50 | $45.60 | $3,146 |
| 76519 Ultrasound - Nonspecific | Office | 64 | 26 | $29.46 | $1,885 |
| 92202 Ophthalmological E&M | Office | 60 | 59 | $10.39 | $623 |
| 92134 Computerized Ophthalmic Imaging | Office | 56 | 54 | $30.06 | $1,683 |
| 92004 Ophthalmological E&M | Office | 51 | 51 | $104.81 | $5,345 |
| 92133 Computerized Ophthalmic Imaging | Office | 46 | 34 | $27.04 | $1,244 |
| 92235 Angiography | Office | 42 | 42 | $128.63 | $5,402 |
| 66984 Cataract Surgery | Facility | 39 | 26 | $423.37 | $17K |
| 99304 SNF E&M | Facility | 28 | 26 | $57.41 | $1,608 |
| 92250 Angiography | Office | 17 | 17 | $31.03 | $528 |
By year: 2022 $118K for 1,162 services; 2023 $104K for 1,038 services; 2024 $85K for 922 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jacqueline Dauhajre prescribed most often to Medicare patients was Xiidra (Lifitegrast), with 3,139 prescriptions and refills. In total Jacqueline Dauhajre wrote 15,459 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xiidra Lifitegrast | 3,139 | 3,546 | 808 | $2.3M |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,987 | 2,933 | 411 | $27K |
| Prednisolone Acetate Generic | 1,899 | 1,935 | 936 | $52K |
| Latanoprost Generic | 1,678 | 1,877 | 317 | $9,191 |
| Lumigan Bimatoprost | 1,375 | 2,266 | 326 | $612K |
| Miebo Perfluorohexyloctane/Pf | 1,204 | 1,241 | 371 | $906K |
| Ciprofloxacin Hcl Generic | 850 | 854 | 396 | $8,938 |
| Restasis Cyclosporine | 689 | 1,028 | 196 | $612K |
| Combigan Brimonidine Tartrate/Timolol | 550 | 610 | 91 | $128K |
| Brimonidine Tartrate Generic | 512 | 585 | 89 | $4,606 |
| Prolensa Bromfenac Sodium | 338 | 445 | 170 | $113K |
| Vyzulta Latanoprostene Bunod | 220 | 252 | 49 | $68K |
| Besivance Besifloxacin Hcl | 194 | 195 | 83 | $42K |
| Dorzolamide Hcl Generic | 151 | 210 | 43 | $2,074 |
| Brinzolamide Generic | 76 | 119 | 21 | $9,760 |
Brand drugs: 10,606 claims; generic drugs: 4,853 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jacqueline Dauhajre $2,988 ($2,988 in general payments such as food, travel and fees) from 14 companies. The largest payer was Bausch & Lomb Americas Inc. with $790.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 20 | $790 |
| Alcon Vision LLC ALC | 9 | $440 |
| Biotissue Holdings Inc. | 4 | $295 |
| Tarsus Pharmaceuticals, Inc. TARS | 9 | $272 |
| Glaukos Corporation GKOS | 1 | $204 |
| Shockwave Medical, Inc JNJ | 1 | $201 |
| Abbvie Inc. ABBV | 9 | $150 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $146 |
| Sight Sciences, Inc. SGHT | 1 | $144 |
| Harrow Eye, LLC | 4 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.